Prophylactic tranexamic acid appears to be safe and is associated with reduced bleeding in general surgery. However, its ...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best small cap stocks to buy with huge upside potential. H.C.
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
Pfizer disclosed a patient death in a marstacimab hemophilia study, triggering a safety review and reassessment of surgical ...
Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...
A new study reveals that antimicrobial resistance is rising worldwide - eroding the effectiveness of last-line antibiotics ...
CAAR held that wheat seed oil ceramides subjected to purification and standardisation cannot be treated as simple vegetable ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
CytomX Therapeutics, Inc. is downgraded to Hold ahead of key CX-2051 Phase 1 expansion data in 1Q26. Learn more about CTMX ...
Long-term follow-up of Taiwanese children with chronic hepatitis B virus (HBV) infection showed that 3.29% had HBV surface antigen (HBsAg) seroconversion after antiviral treatment while another 3.86% ...
Real-world data comparing two negative-pressure wound therapy devices suggests lower pressure may drive better outcomes. Around seven million orthopedic surgeries take place in the U.S. every year1, ...
The "Von Willebrand Disease Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives navigating the rare disease pharmaceutical ...